Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00510237
Other study ID # ATN 068
Secondary ID
Status Completed
Phase N/A
First received July 31, 2007
Last updated March 2, 2017
Start date February 2007
Est. completion date January 2009

Study information

Verified date August 2016
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of adolescents who have recently been diagnosed with HIV.


Description:

The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.

Individual Session I: Orientation I

Part A - meet with interventionist for ecological assessment, rapport building, and preparation for meeting with medical provider Part B - meet with medical provider to answer HIV specific medical questions (i.e., transmission information, viral load/t-cells, opportunistic infections,etc.). The interventionist will be present in Part B as well.

Individual Session II: Orientation II

Part A - meet with interventionist for continued debriefing, question/answer, preparation for group participation.

Part B - meet with peer facilitator to discuss individual experiences living with HIV, rapport building, peer-specific questions. The interventionist will be present in Part B as well.

Individual session III: Wrap-up and Action Planning (to take place after group sessions are complete)

Part A - action plan with linkage to identified agencies via facilitated referrals Part B - (optional) support building - participants may bring parents, partner, friend, or other potential source of support for question/answer session with interventionist

Session I: Developing Group Cohesion

- Icebreaker, team building, group rules, facilitation of group "ownership" by participants.

Session II: Disclosure, Stigma & Relationships

- Disclosure to family, friends, peers and co-workers as well as dealing with stigma associated with HIV/AIDS;

- Concerns about current or future romantic and/or sexual relationships, including discussion of safer sex, condom use, sero-discordant couples.

Session III: Preparing for Medical Intervention

- Working with medical providers, an overview of clinic appointments and expectations surrounding attendance, a preliminary discussion of medications, side effects, and medical management as well as strategies for adherence.

Session IV: Healthy Living

- Issues related to drugs and alcohol;

- Leisure activities such as sports and entertainment;

- Self-care including nutrition and exercise;

- The importance of school and work.

Session V: Stress Reduction/Relaxation & Spirituality

- Techniques including deep breathing, progressive muscle relaxation, visualization, meditation and self-hypnosis;

- Self-care including complimentary therapies such as massage and acupuncture

- Spirituality;

- Planning social outings and activities.

Session VI: Gender Specific

- Males: issues surrounding sexuality and sexual orientation, male role of caring for self, loved ones, and the community;

- Females: issues surrounding sexuality, pregnancy and parenting, female role of caring for self, loved ones, and the community.

Session VII: Self-Esteem/Self-Worth

- Strategies to improve self-esteem and self-worth;

Session VIII: Legal Issues/Advocacy

- Legal rights and advocacy;

- Linkage to community advocacy groups;

- Preparing to become a speaker/advocate;

- Health insurance/life insurance.

Session IX: Future Planning

- Planning for the future including issues related to work and school (e.g., job application process, applying for financial aid), job training and career choices.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 2009
Est. primary completion date June 2008
Accepts healthy volunteers No
Gender All
Age group 16 Years to 24 Years
Eligibility Inclusion Criteria:

To be considered eligible for enrollment in ATN 068, a participant must meet the criteria listed below:

- Receive services at one of the 4 selected ATN sites or their community partners;

- HIV-infected as documented by medical record review or verbal verification with referring professional;

- Received HIV diagnosis less than 15 months ago as documented by medical record review or verbal verification with referring professional;

- Fall between the ages of 16-24 (inclusive) at the time of informed consent/assent;

- Must be willing to participate in the both the individual and group sessions;

- Give informed consent/assent for study participation.

Exclusion Criteria:

Participants who meet any of the exclusion criteria listed below are considered ineligible:

- Acquired HIV through perinatal infection;

- Presence of serious psychiatric symptoms (active hallucinations, thought disorder);

- Visibly distraught (suicidal, homicidal, exhibiting violent behavior);

- Intoxicated or under the influence of alcohol or other substances at the time of study enrollment.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
"Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.

Locations

Country Name City State
United States Montefiore Medical Center Bronx New York
United States John Stroger Jr. Hospital of Cook County Chicago Illinois
United States St. Jude Children's Research Hospital Memphis Tennessee
United States University of Miami School of Medicine Miami Florida

Sponsors (3)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The best procedures for a larger trial (e.g. timing, content etc. of ACASI administration) 7 months
Primary The appropriateness of specific instruments proposed. 7 months
Primary The perceived sensitivity of measures to change over time. 7 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2